Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.
2.

HER2-positive breast cancer: update on Breast Cancer International Research Group trials.

Nabholtz JM, Reese DM, Lindsay MA, Riva A.

Clin Breast Cancer. 2002 Oct;3 Suppl 2:S75-9. Review.

PMID:
12435291
3.

Pertuzumab for the treatment of patients with previously untreated HER2-positive metastatic breast cancer.

Smith MB, Reardon J, Olson EM.

Drugs Today (Barc). 2012 Nov;48(11):713-22. doi: 10.1358/dot.2012.48.11.1885879. Review.

4.

Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: a case report and review of the literature.

Ihnenfeld ArciƩnega I, Imesch P, Fink D, Dedes KJ.

Target Oncol. 2015 Jun;10(2):297-301. doi: 10.1007/s11523-014-0350-9. Epub 2014 Dec 17. Review.

5.

Combining the anti-HER2 antibody trastuzumab with taxanes in breast cancer: results and trial considerations.

Pegram MD, O'Callaghan C.

Clin Breast Cancer. 2001 Oct;2 Suppl 1:S15-9. Review.

PMID:
11970740
6.

CA 125 elevation in breast cancer: a case report and review of the literature.

Leonard GD, Low JA, Berman AW, Swain SM.

Breast J. 2004 Mar-Apr;10(2):146-9. Review.

PMID:
15009043

Supplemental Content

Support Center